Therapeutic Exploratory (Phase II)

3,454 trials 1,368 recruiting

Filter these 3,454 trials by condition, country, sponsor and more.

Open in Search →

Blood-borne Assessment of Stromal activation in esophageAL adenocarcinoma to guide tocilizumab Therapy: a randomized phase II proof-of-conce… Ended

2023-509458-77-00 Esophageal adenocarcinoma, esophageal cancer 2021-01-04
A study on the efficacy and safety of cisplatin/etoposide and concomitant radiotherapy in combination with durvalumab, an immunotherapy, in … Ended

2024-513433-20-00 Limited Disease Small Cell Lung Cancer 2020-12-16
18F-Fluorocholine (FCH) versus 18F-Fluorodesoxyglucose (FDG) PET/CT for the detection of lesions in patients with multiple myeloma Ended

2024-516682-36-00 Patients diagnosed with multiple myeloma 2020-12-15
GYNET : A randomized, multicenter, open label, Phase I/II study to evaluate the safety (Phase I - safety run in), clinical and biological ac… Ended

2024-510714-32-00 Patiens with locally advanced/metastatic endometrial ca 2020-12-10
A clinical study of belzutifan for treatment of kidney cancer (MK-6482-013) Ended

2022-502123-21-00 Advanced Renal Cell Carcinoma 2020-12-08
The study of Trastuzumab Deruxtecan to assess its efficacy, safety and tolerability in Patients with Selected HER2 Expressing Tumors Ended

2023-504721-39-02 HER2 Expressing Tumors 2020-12-07
Methotrexate and Metformin in rheumatoid arthritis patients. Ended

2024-511033-35-00 rheumatoid arthritis (RA) 2020-12-03
Comparison of two strategies that use the same drugs but with inverted sequence for the treatment of patients with metastatic colorectal can… Ended

2024-513296-41-00 Colorectal cancer spread at distance, RAS BRAF wild typ 2020-12-03
TALAMESO : A Three-Cohort Phase II trial to Assess the Efficacy of a Maintenance Treatment with TALAzoparib following First Line Platinum-ba… Ended

2024-514104-14-00 Adults subjects with advanced malignant pleural (cohort 2020-11-04
A Phase 2, Open-Label, Multi-Center Study of Venetoclax in Combination with Carfilzomib and Dexamethasone in Subjects with Relapsed or Refra… Ended

2023-505659-27-00 Multiple Myeloma 2020-10-21
Evaluation of a treatment with bendamustine, followed by obinutuzumab, zanubrutinib and venetoclax in patients with relapsed chronic lymphoc… Ended

2022-502201-16-00 Relapsed/refractory chronic lymphocytic leukemia 2020-09-30
A study of mitapivat in sickle cell disease Ended

2024-515569-32-00 Sickle cell disease 2020-09-24
CLINICAL TRIAL WITH MESENCHYMAL STEM CELLS IN STROKE PATIENTS Ended

2024-512514-18-00 ISCHEMIC STROKE 2020-09-17
Effect of impact of PCSK9 inhibitor on coronary microvascular dysfunction in patients with atherosclerotic cardiovascular disease needing co… Ended

2024-519012-14-00 atherosclerotic cardiovascular disease 2020-09-15
Clinical trial to compare efficacy and safety of standard chemotherapy versus letrozole plus abemaciclib, chosen randomly, as neoadjuvant th… Ended

2024-514395-40-00 High/intermediate risk hormone receptor (HR) positive/h 2020-08-25
Reduced intensity radio-chemotherapy for stage IIA/B seminoma Ended

2023-509663-24-00 Stage IIA/B seminoma 2020-08-20
Study with apalutamide in patients with prostate cancer in whom the prostate has been removed who are at high risk of disease recurrence Ended

2024-511832-29-00 High risk adenocarcinoma of the prostate after radical 2020-08-05
Rituximab from the first episode of Minimal Change Nephrotic Syndrome for preventing relapse risk in adult patients Ended

2024-516102-36-00 Minimal Change Nephrotic Syndrom 2020-07-29
Venetoclax and Dexamethasone in translocation (11;14) positive relapsed and refractory multiple myeloma (VICTORIA) Ended

2024-512731-74-00 multiple myeloma 2020-07-03
Tocotrienol and bevacizumab in metastatic colorectal cancer. A randomized phase II marker trial Ended

2024-517075-21-00 Metastatic Colorectal cancer 2020-06-26
Efficacy and Safety of L19TNF in Previously Treated Patients With Advanced Stage or Metastatic Soft-tissue Sarcoma Ended

2024-512704-20-00 Unresectable and/or metastatic soft-tissue sarcoma afte 2020-06-22
A Prospective Phase II Clinical Trial Evaluating the Efficacy and the Safety of Tyrosine Kinase Inhibitors Withdrawal After a Previous Two-s… Ended

2024-514592-17-00 chronic myeloid leukemia 2020-06-16
A study to look at how safe and effective glofitamab plus R-CHOP in ctDNA high-risk people with untreated diffuse large B-cell lymphoma Ended

2023-504994-19-00 Diffuse Large B-Cell Lymphoma 2020-06-12
Targeting triple negative BREAst cancer metabolism with a combination of chemotherapy and a diet mimicking FASTing plus/minus metformin in t… Ended

2023-508920-37-00 Triple negative breast cancer 2020-05-20